Search clinical trials for: Human immunodeficiency virus (HIV) infections

Total 72273 results

Harvard School of Public Health (HSPH)
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaborators

Recruiting

Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up) (AMP Up)

HIV/AIDS

United States, Puerto Rico
University of Sao Paulo General Hospital

Completed

Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus

HIV Infection
Gilead Sciences

Active, not recruiting

Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2- Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen

HIV-1

United States, Panama, South Africa
Abivax S.A.

Completed

Safety, PK and PD Study of ABX464 in Untreated HIV Patients

Human Immunodeficiency Virus Infections

Thailand, Mauritius
National Institute of Allergy and Infectious Diseases...

Completed

Analysis of Immune Responses to HIV Vaccines

HIV Infections | Acquired Immunodeficiency Syndrome

United States
Centers for Disease Control and Prevention
Gilead Sciences; Botswana Ministry of Health

Terminated

Botswana Tenofovir Oral HIV Prophylaxis Trial

HIV Infection

United States, Botswana
Pfizer

Withdrawn

Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients

Human Immunodeficiency Virus
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

HIV Infections | HIV Seronegativity

United States
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018) (DRIVE-FORWARD)

HIV-1
University of Illinois at Chicago
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

PHAT Life: Peer Versus Adult-Led HIV Prevention for Juvenile Offenders (PHATLife)

HIV/AIDS

United States
Organization to Achieve Solutions in Substance...

Unknown

Integrating Buprenorphine Into HIV Treatment

HIV Infections | Opiate Dependence

United States
London School of Hygiene and Tropical Medicine
University College, London; UNITAID; Liverpool School of Tropical Medicine; Population... and other collaborators

Completed

A Cluster Randomised Trial of Community-led Distribution of HIV Self-tests in Rural Malawi (HIV Self-Testing Africa [STAR])

HIV/AIDS

Malawi
Massachusetts General Hospital
National Institute of Mental Health (NIMH)

Completed

Two Approaches to Routine HIV Testing in a Hospital Emergency Department (USHER)

HIV Infections

United States
OncoImmune, Inc.
University of Maryland, Baltimore

Terminated

Efprezimod Alfa (CD24Fc, MK-7110) Administration to Decrease Low-Density Lipoprotein (LDL) and Inflammation in Human Immunodeficiency Virus (HIV) Patients (CALIBER) (MK-7110-003) (CALIBER)

HIV Infections | Dyslipidemias

United States
VaxGen

Completed

A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines

HIV Infections

United States
Henry M. Jackson Foundation for the Advancement...
US Military HIV Research Program; Janssen Vaccines & Prevention B.V.

Withdrawn

Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission (RV582)

HIV-1-infection

Thailand
Rigshospitalet, Denmark
Merck Sharp & Dohme LLC

Completed

Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark

HIV Infections

Denmark
Microbicide Trials Network
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Rectal Microbicide Acceptability, Tolerability and Adherence

HIV Prevention

United States, Malawi, Peru, South Africa, Thailand
Pfizer

Completed

Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen

Human Immunodeficiency Virus

United States, Spain, South Africa, Italy, France, Germany
University of California, San Francisco
National Institute on Minority Health and Health Disparities (NIMHD); Florida...

Recruiting

The OPENS Trial: Offering Women PrEP (Aim 2)

Sexually Transmitted Diseases | Human Immunodeficiency Virus | Human Immunodeficiency Virus Transmission

United States
Alexion
Achillion, a wholly owned subsidiary of Alexion

Completed

Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants

HIV Infections

United States, Puerto Rico
Medical College of Wisconsin

Active, not recruiting

Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities (SNAP)

Human Immunodeficiency Virus

United States
Columbia University
National Institute on Drug Abuse (NIDA)

Completed

BRIDGE: Improving HIV Service Delivery for People Who Inject Drugs

Substance Abuse, Intravenous | Human Immunodeficiency Virus

United States, Kazakhstan
National Institute of Allergy and Infectious Diseases...
IPPOX Foundation; EuroVacc Foundation; Global Solutions for Infectious Diseases

Withdrawn

Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults

HIV Infections
United Biomedical

Completed

A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects

HIV Infections

United States
Institute of HIV Research and Innovation Foundation...
National Institutes of Health (NIH); amfAR, The Foundation for AIDS Research

Recruiting

Anal HSIL Screening Algorithm (0007/65)

Anal High-grade Squamous Intraepithelial Lesion

Thailand
University of California, Los Angeles
National Institute of Allergy and Infectious Diseases (NIAID); CONRAD

Completed

Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally

HIV Infections

United States
International AIDS Vaccine Initiative
National Institute of Allergy and Infectious Diseases (NIAID); Beth Israel... and other collaborators

Completed

Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adults

HIV Infections

United States, Kenya, Rwanda, South Africa
Bristol-Myers Squibb

Completed

A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex

HIV Infections | AIDS Dementia Complex

United States, Australia, United Kingdom
National Institute of Allergy and Infectious Diseases...

Unknown

Resistance to HIV Infection

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
GeoVax, Inc.

Completed

Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults

HIV Infections

United States
Kirby Institute
Chelsea and Westminster NHS Foundation Trust

Completed

The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)

HIV Infection

Argentina, South Africa, Thailand, United Kingdom
Germans Trias i Pujol Hospital

Completed

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

HIV Infections | HIV

Spain
Merck Sharp & Dohme LLC
HIV Vaccine Trials Network

Terminated

Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)

HIV Infections | AIDS
Kirby Institute
Imperial College London

Completed

The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1 (ENCORE1-CNS)

HIV Infection

Thailand, Germany, United Kingdom
Wits Health Consortium (Pty) Ltd
Perinatal HIV Research Unit of the University of the Witswatersrand; PharmaCentrix...

Terminated

PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 (PHRUCov01)

Covid19

South Africa
World Bank
Department for International Development, United Kingdom; Wits Reproductive... and other collaborators

Completed

Smart Linkage-to-HIV Care Via a Smartphone App (SmartLtC)

HIV Infections | Antiretroviral Therapy | Patient Compliance | Viral Load | Cell Phone

South Africa
Academisch Medisch Centrum - Universiteit van Amsterdam...
Dutch AIDS Fund

Terminated

Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients

HIV Infections

Netherlands
Medical College of Wisconsin

Recruiting

IMB-guided Intervention to Encourage PrEP Uptake Among Young Men Who Have Sex With Men

Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline

Completed

A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761

HIV Infections | Infection, Human Immunodeficiency Virus

United States
National Institute of Allergy and Infectious Diseases...
National Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute... and other collaborators

Completed

A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

HIV Infections | Herpes Genitalis | HIV Seronegativity

United States
Evandro Chagas National Institute of Infectious...
Valdiléa Veloso dos Santos, Ph.D.; Beatriz Grinzstejn, MD, PhD; Brenda Hoagland... and other collaborators

Completed

Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study (Seroincidence)

HIV Infections | Risk Behavior | HIV Seropositivity | Risk Reduction | STD | HIV Infection Primary | Risky Health Behavior

Brazil
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.

Completed

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

HIV Infections

United States
SmithKline Beecham

Completed

Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)

HIV Infections | Leukoencephalopathy, Progressive Multifocal

United States
Gilead Sciences

Completed

Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir

HIV Infection

Canada, Germany, United States, Spain, France, Australia, Puerto Rico, Italy, Belgium, Mexico, Switzerland, Portugal, Netherlands, United Kingdom
University of Connecticut
National Institute of Mental Health (NIMH)

Completed

Adherence Intervention for People With Low-literacy

HIV Infections

United States
The HIV Netherlands Australia Thailand Research...
Roche Pharma AG; Kirby Institute; International Antiviral Therapy Evaluation...

Completed

The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients

HIV Infections

Thailand
University of Connecticut
National Institute of Mental Health (NIMH)

Completed

HIV Prevention Intervention for People Living With HIV/AIDS

HIV Infections

United States
University Hospital, Essen

Recruiting

HIV-HEART Aging Study (HIVH)

Myocardial Infarction | HIV Infections | Heart Failure | Coronary Disease | Aging | Weight Gain | HIV Encephalopathy

Germany
University Hospital, Essen
Federal Ministry of Education and Reserach (BMBF)

Completed

Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)

Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection. | Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors, | HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral...

Germany

Search clinical trials for: Human immunodeficiency virus (HIV) infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations